suomi.fi
Go directly to contents.
Responsible for the service The Board for Gene Technology

Public consultation on field trials with genetically modified organisms (GMOs)

  • Service
  • Nationwide
  • Public service

You have the opportunity to express your opinion on planned field trials using living genetically modified organisms (GMOs) in Finland. However, there is no hearing in situations where it could endanger a person's life, health or the privacy of the patient. This exception may apply, for example, to clinical trials of a genetically modified pharmaceutical for treating a rare disease or to urgent treatment of individual patients.

In certain special cases, the Board for Gene Technology may also organise a similar public consultation on the contained use of GMOs.

The public consultation shall take 60 days for each application.

Do the following

Information on new field trial applications will be published on the website of the Board for Gene Technology and in the Official Journal. You can also join the mailing list so that you will always be notified by email of a new application.

During the hearing period, you can send your comments by letter or e-mail to the Board for Gene Technology.

To whom and on what terms

All interested parties may submit their opinions and comments. Note, however, that a field trial permit may only be refused to the applicant if the planned experiment would involve health or environmental hazards that cannot be prevented by risk management measures.

The service is free of charge.

Background information

Basic information

The service is provided byThe Board for Gene Technology
Responsible for the serviceThe Board for Gene Technology
Area Whole Finland
Available languagesFinnish, Swedish
Text edited by: The Board for Gene Technology
Updated: 8/3/2021